211 related articles for article (PubMed ID: 21183733)
1. Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease.
Pedersen ER; Midttun Ø; Ueland PM; Schartum-Hansen H; Seifert R; Igland J; Nordrehaug JE; Ebbing M; Svingen G; Bleie Ø; Berge R; Nygård O
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):698-704. PubMed ID: 21183733
[TBL] [Abstract][Full Text] [Related]
2. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study.
Sulo G; Vollset SE; Nygård O; Midttun Ø; Ueland PM; Eussen SJ; Pedersen ER; Tell GS
Int J Cardiol; 2013 Sep; 168(2):1435-40. PubMed ID: 23336953
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study.
Apalset EM; Gjesdal CG; Ueland PM; Øyen J; Meyer K; Midttun Ø; Eide GE; Tell GS
Osteoporos Int; 2014 Aug; 25(8):2067-75. PubMed ID: 24817202
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
Zuo H; Tell GS; Vollset SE; Ueland PM; Nygård O; Midttun Ø; Meyer K; Ulvik A; Eussen SJ
Cancer; 2014 Nov; 120(21):3370-7. PubMed ID: 24948355
[TBL] [Abstract][Full Text] [Related]
5. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
[TBL] [Abstract][Full Text] [Related]
6. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease.
Karlsson T; Strand E; Dierkes J; Drevon CA; Øyen J; Midttun Ø; Ueland PM; Gudbrandsen OA; Pedersen ER; Nygård O
Eur J Nutr; 2017 Feb; 56(1):261-272. PubMed ID: 26482150
[TBL] [Abstract][Full Text] [Related]
7. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris.
Pedersen ER; Tuseth N; Eussen SJ; Ueland PM; Strand E; Svingen GF; Midttun Ø; Meyer K; Mellgren G; Ulvik A; Nordrehaug JE; Nilsen DW; Nygård O
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):455-62. PubMed ID: 25524770
[TBL] [Abstract][Full Text] [Related]
8. Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study.
Apalset EM; Gjesdal CG; Ueland PM; Midttun Ø; Ulvik A; Eide GE; Meyer K; Tell GS
Clin Exp Immunol; 2014 Jun; 176(3):452-60. PubMed ID: 24528145
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography.
Pedersen ER; Svingen GF; Schartum-Hansen H; Ueland PM; Ebbing M; Nordrehaug JE; Igland J; Seifert R; Nilsen RM; Nygård O
Eur Heart J; 2013 Sep; 34(34):2689-96. PubMed ID: 23886918
[TBL] [Abstract][Full Text] [Related]
10. Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris.
Eschen O; Christensen JH; Johnsen SP; Dethlefsen C; Schmidt EB
Scand Cardiovasc J; 2010 Jun; 44(3):153-60. PubMed ID: 20184510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.
Avanzas P; Arroyo-Espliguero R; Quiles J; Roy D; Kaski JC
Eur Heart J; 2005 Mar; 26(5):457-63. PubMed ID: 15684278
[TBL] [Abstract][Full Text] [Related]
13. Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris.
Estévez-Loureiro R; Recio-Mayoral A; Sieira-Rodríguez-Moret JA; Trallero-Araguás E; Kaski JC
Atherosclerosis; 2009 Dec; 207(2):514-8. PubMed ID: 19577753
[TBL] [Abstract][Full Text] [Related]
14. Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study.
Zuo H; Ueland PM; Ulvik A; Eussen SJ; Vollset SE; Nygård O; Midttun Ø; Theofylaktopoulou D; Meyer K; Tell GS
Am J Epidemiol; 2016 Feb; 183(4):249-58. PubMed ID: 26823439
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
Mjelva ØR; Svingen GFT; Pedersen EKR; Seifert R; Kvaløy JT; Midttun Ø; Ueland PM; Nordrehaug JE; Nygård O; Nilsen DWT
Thromb Haemost; 2018 Apr; 118(4):778-790. PubMed ID: 29458232
[TBL] [Abstract][Full Text] [Related]
17. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study.
Theofylaktopoulou D; Ulvik A; Midttun Ø; Ueland PM; Vollset SE; Nygård O; Hustad S; Tell GS; Eussen SJ
Br J Nutr; 2014 Oct; 112(7):1065-72. PubMed ID: 25105221
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Ray KK; Morrow DA; Sabatine MS; Shui A; Rifai N; Cannon CP; Braunwald E
Circulation; 2007 Jun; 115(24):3071-8. PubMed ID: 17548728
[TBL] [Abstract][Full Text] [Related]
19. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study.
Vengen IT; Dale AC; Wiseth R; Midthjell K; Videm V
Atherosclerosis; 2009 Nov; 207(1):239-44. PubMed ID: 19409566
[TBL] [Abstract][Full Text] [Related]
20. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.
Christensen MH; Pedersen EK; Nordbø Y; Varhaug JE; Midttun Ø; Ueland PM; Nygård OK; Mellgren G; Lien EA
J Intern Med; 2012 Dec; 272(6):583-91. PubMed ID: 22757621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
